Patients with uveal melanoma tested with decisiondx®-um report gaining value from test results in study conducted in collaboration with the melanoma research foundation's cure om initiative

Friendswood, texas--(business wire)---- $cstl #cstl--castle announced findings from a study that evaluated uveal melanoma patients' attitudes toward prognostic testing with decisiondx-um®.

CSTL Ratings Summary

CSTL Quant Ranking